Colon Cancer Resection

Covers general oncologic principles and technique for right-sided, transverse, splenic flexure, descending, and sigmoid colon cancer resections. Rectal cancer surgery (TME, LAR, APR) is covered separately (see Total Mesorectal Excision (TME) & Sphincter-Sparing Resection and Abdominoperineal Resection (APR)). Content below is from two textbook reference chapters (Sabiston Ch52 - Colorectal Neoplasia & Colon Cancer Surgery and ASCRS Ch25 - Colon Cancer Surgical Treatment), not primary literature.

Preoperative tumor localization

Mislocalization of the tumor based on preoperative colonoscopy alone occurs in 11–21% of cases and can result in a different surgical procedure than originally planned in 11% of cases — even higher when cecal/rectal tumors (which have more reliable landmarks) are excluded, given the lack of definitive landmarks and anatomic variation in the distal ascending, transverse, and left colon. "Centimeters from the anal verge" should never be relied upon, since this measurement is often highly inaccurate on flexible colonoscopy — particularly important for rectosigmoid tumors, where misclassification can lead to inappropriate treatment (many experienced colorectal surgeons repeat flexible sigmoidoscopy on any patient referred with a neoplasm anywhere in the left colon, to avoid mistakenly taking a rectal cancer patient directly to the operating room for colectomy instead of proctectomy — see Colorectal Cancer Staging (TNM)'s Diagnostic workup section for the broader proctoscopy/localization framework this specific pitfall sits within).

Preoperative CT can sometimes demonstrate tumor location directly, but the tumor is often too small to see definitively, so other localization methods should be considered:

Endoscopic tattooing at the time of colonoscopic tumor identification — facilitates intraoperative localization, especially for minimally invasive colectomy where palpation isn't possible. India ink is typically used, injected into the submucosal plane (full-thickness injection sprays ink throughout the abdomen and can make localization more difficult). One technique: first inject 0.5–1.0 mL of saline to create a submucosal bleb, then inject the India ink into the bleb — repeated in three or more quadrants to avoid a mesenteric-only injection (do not inject directly into the tumor or the wall opposite it — just distal to the tumor). Preferable to tattoo only distal to the tumor (not both proximal and distal), since the distal extent is usually most critical for planning resection — with only one tattoo site, it can be identified intraoperatively unambiguously. Even with tattoo placement, the tumor/tattoo can be difficult to discern intraoperatively (ink dispersed throughout the abdomen, mesenteric-quadrant-only placement, inadequate ink amount, obesity, adhesions) — surgeons should always be prepared for the possibility of intraoperative colonoscopy (ideally with CO₂ insufflation to limit bowel dilatation) when the tumor can't be definitively identified on preoperative imaging.
Metallic clip placement adjacent to the tumor at colonoscopy, as an alternative/adjunct — plain radiographs performed immediately post-colonoscopy (while the colon is still gas-filled) can show the clip's location relative to the colon outline, or staging CT performed shortly after colonoscopy/clip placement can localize it if the clip remains in situ. May be especially useful when tattoo ink is unavailable at colonoscopy.

Goal and general principles

The goal of curative surgery is resection of the primary tumor with adequate free margins, en bloc, with locoregional lymphadenectomy. Regional lymph nodes are located in the mesocolon along the main vascular pedicles. An oncologically adequate resection removes the portion of colon supplied by the vascular pedicle(s) serving the tumor's location, ligated and divided at their origin, and removes the mesentery at greatest risk for lymphatic spread.

Surgery should be gentle; tumor manipulation should be minimized (no-touch technique — vascular pedicle ligated before colon mobilization, developed out of concern that tumor manipulation dislodges circulating tumor cells (CTCs) into the bloodstream). Initial single-arm studies showed prognostic promise, but follow-up trials — including a recent RCT of conventional vs. no-touch colectomy — failed to reproduce a disease-free, overall, or recurrence-free survival difference in stage II/III colon cancer, and a study directly assaying blood samples for CTCs found no evidence that manipulation caused detachment. The no-touch technique's benefit remains unproven, despite continuing to be taught as a principle.
Margins: colon cancer — a 5-cm "free" margin is recommended both proximally and distally, to minimize anastomotic-recurrence risk and to avoid leaving behind perivisceral lymph nodes that could harbor metastatic disease — adhering to 5-cm margins has been shown to minimize anastomotic recurrences specifically. With high ligation of the feeding vessel, it is unlikely to fail to obtain 5-cm margins given the resultant ischemia of the colon both proximally and distally. Proximal ligation of feeding vessels should be performed to maximize lymphadenectomy. Colectomy specimens should have the non-peritonealized margins marked with ink (preferably by the surgeon) to assess completeness of resection, as is routine for proctectomy specimens for rectal cancer. Rectal cancer — a 2-cm distal margin is sufficient (distal spread occurs in only 1–2% of cases when the distal margin is 2 cm); in ultradistal sphincter-sparing surgery, a 1-cm cancer-free margin, or a margin confirmed at frozen section, can be accepted in selected cases.
The anastomosis must be constructed without tension, using well-vascularized bowel segments. Colon vascular supply for the anastomosis relies on marginal vessels in the mesocolon — minimal injury to these vessels during mobilization/manipulation can cause irreversible ischemic damage to the transposed colon.

Lymphadenectomy

A lymphadenectomy is considered adequate when feeding vessels are taken at their origin and at least 12 lymph nodes have been harvested and examined histologically — this enables accurate cancer staging, which is imperative for selecting patients for adjuvant therapy. The number of harvested lymph nodes and the ratio of involved-to-harvested nodes (lymph node ratio, LNR — see Colorectal Cancer Staging (TNM)'s Prognostic factors section for LNR's prognostic role) can be used as markers of adequacy of surgical resection and are associated with patient outcomes, though the extent of lymph node resection needed is debated. The role of extended lymphadenectomy for synchronous extra-regional lymph node metastasis (e.g., para-aortic nodes) is even more controversial — one study demonstrated benefit for highly selected patients, but this is not standard practice for most colorectal surgeons.

Complete mesocolic excision (CME)

For a much deeper treatment of this topic — Japanese D1/D2/D3(/D4) lymph node classification, anatomical considerations for central vascular ligation, five distinct MIS surgical techniques for right- and left-sided D3 dissection, and outcomes data organized by trial/registry (JCOG0404, Danish DCCG, ERCRC registry, and multiple ongoing RCTs) — see the dedicated page Complete Mesocolic Excision with D3 Lymphadenectomy, sourced from ASCRS Ch37 - Minimally Invasive Complete Mesocolic Excision with Extended Lymphadenectomy for Colon Cancer. The summary below remains from this page's original source chapter.

The aim of mesocolic resection is to remove the tumor, its associated lymphovascular supply (including central vascular ligation), and mesocolon in an intact envelope of visceral peritoneum. No RCTs yet compare CME to "standard" colon surgery; the rationale draws from rectal cancer's survival improvement since the introduction of total mesorectal excision (TME) — the major benefit of CME may in fact be refocusing surgeons on the basic principles of colectomy (cancer-central vessel ligation, removing the mesentery at greatest metastatic-spread risk, negative circumferential margins) just as "TME" did for rectal cancer, since it may be that some surgeons have long been adhering to CME's basic principles before the term was introduced, making it difficult to define precisely what happens during "conventional" surgery for comparison purposes.

Initial retrospective studies show promising oncologic outcomes: Bertelsen et al. reported 5-year outcomes for right-sided colon cancer with CME vs. standard resection showing a significant reduction in 5-year recurrence (9.7% vs. 17.9%) and a difference in median lymph node yield (38 vs. 21). The main demonstrated benefit of CME is this increased lymph node yield — though whether that translates to improved patient survival (vs. simply improving prognostic accuracy) has been questioned by recent studies. Central vessel ligation also obtains central and apical lymph nodes, capturing "skip lesions" (which occur in ~5% of cases on average). Completion of CME with an intact peritoneal lining has been suggested to improve survival by 15%; CME may also standardize surgical resection more generally. Drawbacks: technically more difficult than standard colectomy (longer operative times), with a potential for damage/significant complications given the increased dissection near critical vascular structures (SMA, SMV) — the most feared CME complication is SMV injury, occurring in about 1.6% of right hemicolectomies. Laparoscopic CME has been shown feasible and safe in several studies, with no functional differences noted between CME and conventional colon surgery patients.

Adjacent tissue or organ invasion

Larger colon cancers may invade adjacent structures/organs — most commonly the abdominal wall, bladder, duodenum, omentum, ovaries, peritoneum, retroperitoneum, small bowel, stomach, ureters, and uterus. Adhesions from tumor to other structures are malignant in about 40% of cases; when there is uncertainty whether there is direct invasion vs. mere abutment, en bloc resection is favored — without it, patients are at higher risk of recurrence and decreased survival. Surgical planning should include en bloc resection to achieve negative circumferential margins: for abdominal-wall invasion, en bloc resection with reconstruction; for other organ involvement, complete surgical resection with reconstruction of critical structures (ureters, iliac vessels) if feasible; tail-of-pancreas/splenic invasion can require distal pancreatectomy and splenectomy; pancreatic/duodenal invasion has case reports of en bloc pancreaticoduodenectomy.

Neoadjuvant systemic therapy for locally advanced colon cancer: data from the FOxTROT Collaborative Group showed significant tumor downstaging, less apical lymph node involvement, and fewer positive margins with preoperative treatment in patients with locally advanced, resectable colon cancer — favoring consideration of preoperative treatment. Neoadjuvant chemotherapy was well tolerated and safe, with no increase in perioperative morbidity and a trend toward fewer serious postoperative complications; disease regression was noted in 59% of patients, including some pathologic complete responses, and a decrease in incomplete resection rate was also noted (per an abstract at GI ASCO, not yet full publication). The NCCN recommends considering neoadjuvant therapy in clinical T4b colon cancer specifically, given potential survival benefit. Neoadjuvant chemoradiotherapy can be considered for sigmoid tumors invading the bladder or other pelvic organs (provided the radiation dose to surrounding small bowel can be limited), and has been administered to select patients with more proximal colon tumors invading other vital structures (duodenum, pancreas), though data there are limited to case reports/small series with no definitive conclusions possible. (Cross-link: Colorectal Cancer Staging (TNM)'s Colon vs. rectum delineation section mentions the FOxTROT algorithm in passing — this section is now the detailed home for that data; see also Total Neoadjuvant Therapy (TNT) for the analogous, much more extensively primary-literature- backed rectal-cancer neoadjuvant paradigm.) This FOxTROT/neoadjuvant-colon-cancer data is closely corroborated (not extended) by ASCRS Ch30 - Colorectal Cancer Postoperative Adjuvant Therapy and Surveillance — see Adjuvant Chemotherapy for Colorectal Cancer for that chapter's postoperative adjuvant-chemotherapy content (Stage II/III regimens, IDEA-collaboration duration guidance, molecular profiling), which is genuinely new and not yet covered on this procedure-focused page.

Key vascular landmarks

Ileocolic pedicle originates from the SMA vessels just caudal to the second part of the duodenum.
Middle colic vessels originate from the SMA at the level of the inferior margin of the pancreas.
Inferior mesenteric vein (IMV) is easily identified at the level of the ligament of Treitz.
IMA originates from the aorta 2–3 cm caudal to the area where the IMV is identified; its origin is surrounded by the mesenteric and hypogastric nervous plexus.
Left colic artery originates about 2 cm distal to the IMA's origin.

For sigmoid colon cancer specifically, the level of ligation of the IMA (high vs. low) is controversial — high ligation yields more lymph nodes, but studies have shown no functional or oncologic difference between the two, and there isn't universally agreed nomenclature for exactly what constitutes the IMA vs. its branches (some surgeons consider the IMA to terminate where it branches into the superior hemorrhoidal and left colic arteries — a few centimeters of length; others consider the IMA to include what others call the superior hemorrhoidal artery, a naming convention the chapter calls problematic since it's difficult to say precisely where an artery "crosses" another anatomically, especially after mesosigmoid mobilization).

Surgical approach: open, laparoscopic, robotic

Laparoscopic colorectal resection shows favorable short-term benefits vs. standard open colectomy (less pain, shorter stay, faster bowel function recovery, lower wound infection rate). Resection quality has been shown noninferior for rectal cancer as well, with similar local recurrence and disease-free survival between open and laparoscopic resection — so the laparoscopic approach should be preferred given available expertise. Laparoscopic use for colorectal resections has risen to about 40% over the last decade, with an overall conversion rate below 10% (as high as 80% usage with a low conversion rate at high-volume specialized institutions).

Robotics is described as an evolution of MIS — the surgeon operates from a console with joystick controls, gaining deep 3D vision and intracorporeal hand-wristed movement that overcomes laparoscopy's rigid instruments and 2D vision. RCTs and meta-analyses do not yet show a clear advantage in conversion rate or short-term oncologic outcomes for robotic low anterior resection vs. conventional laparoscopy, but the technology is evolving quickly (single-arm/single-access devices with wristed movement, designed for intrarectal and deep pelvic space use, are in development).

Technical aspects common to all locations: regardless of approach, most patients are positioned supine, unless intraoperative colonoscopy is anticipated, in which case split-leg position is used. The patient's left arm is tucked to allow multiple individuals to stand on the left side, especially for laparoscopic cases. For a medial-to-lateral technique (laparoscopic, robotic, or open), the operating surgeon stands on the left side of the table. For open surgery, a vertical midline or transverse/oblique incision with a self-retaining retractor is used; the abdomen is thoroughly inspected (especially the liver) for metastatic disease, and the tumor is assessed for resectability (including invasion into the duodenum or pancreas).

Right-sided tumors

Right hemicolectomy is the procedure of choice for cancers of the cecum and ascending colon — anatomic resection boundaries approximately 10 cm proximal to the ileocecal valve and to the proximal transverse colon. Includes high ligation of the ileocolic pedicle adjacent to the duodenum (after the duodenum is dissected free and protected), division of the right colic vessels (if present) and the right branch of the middle colic vessels at their origins, and the remaining mesentery to the transverse colon including the marginal artery; the lymphatic tissue surrounding the SMV can be removed en bloc for a complete lymph node dissection. The terminal ileum is divided with a stapler 5–6 cm from the ileocecal valve, and the transverse colon is divided at the junction of its mid and proximal thirds. The right colon is dissected off the white line of Toldt to release the remaining lateral attachments; the lesser sac is often opened to mobilize the transverse colon and complete hepatic flexure mobilization. The omentum is removed en bloc, with the gastrocolic ligament divided along the gastroepiploic arcade. Bowel continuity is restored with an ileotransverse anastomosis, usually latero-lateral — no one anastomotic technique (intracorporeal/ extracorporeal, hand-sewn/stapled, side-to-side/end-to-side/end-to-end) has shown clear superiority. Closure of the mesenteric defect is controversial given its large size and low obstruction risk. Mobilization along anatomic planes is important and improves prognosis.

Open approach: first maneuver is detachment of the right abdominal side-wall attachment; vascular pedicles are ligated once the right colon is fully mobilized from the retroperitoneum and duodenum.
Laparoscopic/robotic (medial-to-lateral) approach: the surgeon first transects the white line of Toldt (usually starting at the cecum and moving toward the hepatic flexure), then mobilizes the colon/mesocolon off the retroperitoneum and duodenum. The hepatic flexure is freed from the liver superiorly and the duodenum posteriorly; the ileocolic, right colic, and right branch of the middle colic vessels are then ligated at their origins.
If laparoscopic, the anastomosis can be extracorporeal (through an umbilical mini-laparotomy, also used for specimen extraction) or intracorporeal. Intracorporeal anastomosis appears to bring advantages — fewer anastomotic complications (leaks/twists) and faster recovery of bowel function/discharge — compared with extracorporeal, but is technically more challenging laparoscopically. The robot facilitates this: anastomoses can be done with an articulated robotic linear stapler, and enterotomies hand-sewn with robotic instruments. Reported leak rates ~1%. Specimen extraction via a Pfannenstiel incision has fewer short- and long-term complications than a midline mini-laparotomy.

Hepatic flexure colon cancer

For lesions in the proximal hepatic flexure, a standard right hemicolectomy may be adequate; depending on more distal location, an extended right hemicolectomy may be required — anatomic resection boundaries from the terminal ileum to the distal transverse colon. The procedure is similar to standard right hemicolectomy, but the vascular division may include the main middle colic arterial trunk, provided there is adequate retrograde flow from the IMA to perfuse the splenic flexure. The lesser sac is opened along its entire length (not just near the hepatic flexure/ proximal transverse colon) to visualize and access the blood supply; the splenic flexure may need mobilization for a tension-free anastomosis.

Removal of the spleen (intentional or not) is associated with high morbidity and increased mortality; inadvertent splenectomies usually result from capsular tear due to inadequate exposure and aggressive retraction during splenic flexure mobilization, with an incidence below 1%. A case- control study (Varty et al.) found no influence on long-term survival from concurrent splenectomy, but increased rates of postoperative sepsis.

Transverse colon tumors

Deciding on the surgical procedure is often challenging, since transverse colon blood supply comes from the middle colic along with the right and left colic vessels — the best procedure removes the regional lymphatic drainage based on the arterial supply/corresponding mesentery, influenced by the tumor's location within the transverse colon and individual anatomy. Options: extended right colectomy, extended left colectomy, or subtotal colectomy.

Proximal transverse colon cancers are typically managed with an extended right colectomy, which differs from a standard right colectomy in that the middle colic vessels are divided at their origin at the level of the inferior margin of the pancreatic neck. The ileocolic anastomosis is made at the distal third of the transverse colon. Indocyanine green (ICG) angiography can assess the vascular supply of the residual colon and identify the area of vascular demarcation — a crucial check when multiple vascular pedicles are resected, or when the viability of the mobilized colon relies on small marginal vessels, especially in elderly atherosclerotic patients.

Mid-to-distal transverse colon lesions may be offered extended right colectomy, extended left colectomy, or segmental transverse colectomy. An extended left colectomy requires ligation of the middle colic artery's main branch in addition to the left colic artery; the resulting anastomosis is ascending-to-descending colon, requiring mobilization of both segments — can be challenging/awkward technically. Segmental transverse colectomy is most appropriate for a mid-transverse tumor with a redundant colon where mobility isn't an issue — an end-to-end colo-colonic anastomosis is usually performed (a side-to-side anastomosis risks tension as the two colonic-mesentery sides retract back toward their original position), though there is also concern about lymphadenectomy adequacy with a segmental resection. For these reasons, many surgeons treat mid-transverse lesions with an extended right colectomy instead, given the easier ileocolic-anastomosis mobilization; a limited segmental transverse colectomy can still be offered for palliative reasons or in frail patients who may not tolerate an extended resection.

Splenic flexure tumors

The ideal procedure for splenic flexure lesions is debated — options range from extended right-sided resection encompassing the splenic flexure, to resection of the splenic flexure alone (left colectomy, involving high ligation of the left colic artery and left branch of the middle colic artery). Typical approach: the IMV is ligated at the level of the ligament of Treitz, the left colic artery is divided at its origin from the IMA, and the specimen is taken en bloc with the omentum. The resultant mesenteric resection includes areas drained by the distal half of the transverse colon and the descending colon; the root of the IMA and superior hemorrhoidal artery is preserved to maintain arterial flow to the remaining sigmoid colon (can be divided if a colorectal, rather than sigmoid-preserving, anastomosis is performed). Bowel continuity is usually restored with a transverse-to-sigmoid colon anastomosis. In selected cases where the transverse colon mesentery is thick and the colon short, this colocolic anastomosis can compress/obstruct the duodenum at the ligament of Treitz — in these cases, an extended right hemicolectomy with ileo-descending anastomosis is preferable. For some proximal splenic flexure lesions, an extended left colectomy with division of the main middle colic artery trunk is indicated.

The patient should be positioned in split leg or low lithotomy to facilitate stapled end-to-end anastomosis and/or endoscopic leak testing.

Descending colon cancer

For tumors in the distal descending colon, a more formal left colectomy includes resection of the sigmoid colon and a colorectal anastomosis. The IMA is isolated and ligated at its origin (with identification/preservation of the left ureter), and the IMV is taken near the ligament of Treitz at the inferior border of the pancreas; the entire left colon from the distal transverse colon to the top of the rectum is removed. To facilitate reach and avoid tension, the IMV should be ligated proximally, the transverse colon mobilized, and omentum released from the stomach; a retroileal anastomosis may be needed in select patients to allow the colon to reach the rectum.

Sigmoid colon cancer

Treated with either a sigmoid colectomy or a left colectomy, depending on tumor location within the sigmoid — more proximal lesions are best served with left colectomy (as above) to ensure adequate lymph node harvest, while tumors in the mid-to-distal sigmoid colon are adequately treated with anterior resection of the rectosigmoid/sigmoid colectomy. No proven oncologic benefit has been shown for formal left colectomy over sigmoid colectomy for distal sigmoid tumors specifically.

An anterior resection is performed for mid/distal sigmoid tumors, patient in low lithotomy. For a medial-to-lateral approach, the peritoneum is incised along the root of the sigmoid mesocolon (from IMA origin to just distal to the sacral promontory); dissection deep to the arc of the superior hemorrhoidal vessels allows identification/preservation of the hypogastric nerves, left ureter, and gonadal vessels. A decision is made whether to divide the IMA at the aorta or preserve the left colic artery and instead divide the superior hemorrhoidal artery at its origin — as noted above, several studies show no survival advantage to "high" ligation of the IMA, though the lack of precise anatomic definitions for what constitutes "high" makes definitive conclusions difficult. The left ureter should be identified and preserved during mobilization/vessel ligation (most ureteral injuries occur at the level of the iliac artery). The distal resection margin is the upper rectum; the proximal margin is typically the junction of the descending and sigmoid colon, ensuring appropriate margins and pulsatile arterial flow to the proximal colon conduit. If there's tension, additional length-creating maneuvers include high ligation of the IMV at the pancreas's inferior border and complete splenic flexure mobilization (some surgeons mobilize the splenic flexure routinely; others selectively). The anastomosis is typically end-to-end with an endoscopic stapler, followed by endoscopic inspection and pneumatic anastomotic leak testing (preferably with CO₂ as the instilled gas).

Special circumstances

Obstructing or perforated colon cancer

About 15% of colon cancer patients present with acute obstruction or perforation. See Obstructing Colon Cancer for the full condition-focused management framework (left- vs. right-sided obstruction management, Hartmann's vs. primary anastomosis evidence, endoscopic stenting) — this section adds procedural technical detail from this chapter not previously covered there: for obstructing right colon tumors, right colectomy is indicated; if the ileocecal valve is competent and the ileum of reasonable caliber, primary anastomosis can be considered in an otherwise-well patient. If the ileum is dilated/edematous, resection with end ileostomy and a mucus fistula (using a corner of the transverse staple line as a vent in the ileostomy opening) can be considered; other options include leaving the closed distal colon segment in the abdomen (only if no synchronous distal large-colon lesions can be ensured), creating a formal colon mucus fistula in the contralateral abdomen, or ileocolic anastomosis with a proximal diverting ileostomy. If the obstruction site is more distal in the colon and there's evidence of proximal colonic ischemia, subtotal colectomy should be strongly considered; the choice of ileosigmoid vs. ileorectal anastomosis (or none, i.e., Hartmann's/proximal diversion) again depends on bowel condition and the patient's acute/chronic status. If the proximal colon is dilated but not ischemic, endoluminal stenting as a bridge to formal resection can be considered; if primary anastomosis (with or without proximal diversion) is performed, intraoperative colonic lavage to clear the diverted stool segment should be considered, to avoid stool extrusion from a leaking anastomosis. For perforated tumors, similar principles apply, plus one additional consideration: the high recurrence rate and need for adjuvant chemotherapy after a perforation — a high-risk anastomosis that may leak (and thereby delay or preclude adjuvant chemotherapy) should be avoided.

Surgical resection for colon cancer in the setting of Lynch syndrome

Approximately 3% of all colorectal cancers arise in the setting of Lynch syndrome, which carries an increased risk of metachronous colon cancer from the underlying genetic predisposition. When a curable colon cancer is diagnosed in this setting, the ASCRS recommends total abdominal or subtotal colectomy over segmental colectomy, given the reduced metachronous-cancer risk afforded by extended resection. This corroborates, without adding new depth beyond, Lynch Syndrome's own much more detailed Surgical management section (same ASCRS guideline citation, Herzig et al. 2017) — see that page for the full decision framework (age/comorbidity/QoL tradeoffs, the 23.5% vs. 6.8% metachronous-CRC registry data, subtotal-colectomy-with-ileosigmoid-anastomosis as an intermediate option, and rectal-cancer-specific considerations in Lynch patients).

Colorectal Cancer Staging (TNM) — tumor localization/tattooing sits within that page's broader diagnostic workup section; the FOxTROT mention there is now backed by full trial detail above.
Obstructing Colon Cancer — the condition-focused counterpart to this page's obstructing-colon- cancer technical detail.
Lynch Syndrome — the full surgical-decision-making detail for Lynch-associated colon cancer, only briefly corroborated above.
Total Neoadjuvant Therapy (TNT) — the analogous, far more extensively primary-literature-backed neoadjuvant paradigm for rectal cancer, contrasted with this page's much thinner colon-cancer neoadjuvant evidence base (FOxTROT abstract-level data only).
Anastomotic Construction — complementary detail on the high-vs-low IMA tie mesenteric-length tradeoff for left-sided/sigmoid resections.
Adjuvant Chemotherapy for Colorectal Cancer — postoperative adjuvant chemotherapy detail (Stage II/III regimens, IDEA-collaboration duration guidance, molecular profiling) not covered on this procedure-focused page.
Complete Mesocolic Excision with D3 Lymphadenectomy — the full deep-dive on CME/D3 dissection terminology, anatomy, technique, and outcomes only summarized in brief above.

Open items / gaps

~~No detail yet on complete mesocolic excision (CME) with central vascular ligation as a distinct technique/controversy — worth checking whether it appears elsewhere in the chapter or needs its own source.~~ Resolved by ASCRS Ch25 - Colon Cancer Surgical Treatment — see the new Complete mesocolic excision (CME) section above.
No primary trial data yet on robotic vs. laparoscopic outcomes specifically — the chapter is explicit that current evidence doesn't show a clear advantage either way.
~~No RCT data on CME vs. standard colectomy — only the retrospective Bertelsen cohort so far.~~ Resolved by ASCRS Ch37 - Minimally Invasive Complete Mesocolic Excision with Extended Lymphadenectomy for Colon Cancer: large multicenter RCT data (5-yr OS 90.4% vs. 91.8%, DFS 80% vs. 79%) and JCOG0404 now exist comparing D3/CME to D2 dissection — see Complete Mesocolic Excision with D3 Lymphadenectomy for full detail. Note this chapter's terminology differs from the Japanese D1/D2/D3 framework used in Ch37 — "standard" resection here roughly maps to D2, not D1.
FOxTROT's downstaging/margin/regression data is cited by this chapter only at the abstract/ conference-report level for one endpoint (incomplete resection rate) — full peer-reviewed publication not yet independently ingested.

Colorectal LLM Wiki